Science & Enterprise subscription

Follow us on Twitter

  • Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-1… https://t.co/AtztCHfZLl
    about 11 hours ago
  • New post on Science and Enterprise: Antibodies Help Some Hospitalized Covid-19 Patients https://t.co/lJhns0fZzJ #Science #Business
    about 11 hours ago
  • https://t.co/BUeUy0ajO3 ... Crocodile on the Tarcoles River in Costa Rica, for #NaturePhotographyDay ... February 2020.
    about 1 day ago
  • https://t.co/mtU98giel5 Oystercatcher for #NaturePhotographyDay ... Cape May, New Jersey. June 2019.
    about 1 day ago
  • Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotr… https://t.co/7tbDhyf5lv
    about 1 day ago

Please share Science & Enterprise

U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal

Capsules

Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA. . . . → Read More: U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal

FDA Okays Lower Dose, Injected Covid-19 Antibodies

Intradermal injection

The Food and Drug Administration updated its emergency authorization for a dual-antibody Covid-19 therapy to allow for a lower and injectable dose. . . . → Read More: FDA Okays Lower Dose, Injected Covid-19 Antibodies

Infographic – U.S. Kids Vaccine Status Matches Parents

Poll: Vaccination status

Findings from the YouGov poll show the likelihood of children in the U.S. getting a Covid-19 vaccine depends largely on their parents’ vaccination status or plans. . . . → Read More: Infographic – U.S. Kids Vaccine Status Matches Parents

Antibody Clears Covid-19 Variants, Enters Trial

SARS-Cov-2 virus

A synthetic antibody is shown in lab tests to neutralize variants of the SARS-CoV-2 virus, and will be added to an ongoing clinical trial of Covid-19 therapies. . . . → Read More: Antibody Clears Covid-19 Variants, Enters Trial

Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

SARS-CoV-2 and cell

Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab alone to treat for Covid-19 infections. . . . → Read More: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance

Trial to Test Direct Crispr Blood Stem Cell Edits

Sickle cells illustration

A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease. . . . → Read More: Trial to Test Direct Crispr Blood Stem Cell Edits

FDA Clears Covid-19 Nasal Spray/Drops Vaccine Trial

Nasal spray

A company developing vaccines delivered through the nose received FDA clearance to begin a clinical trial of its vaccine protecting against Covid-19 infections. . . . → Read More: FDA Clears Covid-19 Nasal Spray/Drops Vaccine Trial

FDA Authorizes Non-Prescription Covid-19 Test

Cue Covid-19 test

Food and Drug Administration granted an emergency authorization for a molecular test for SARS-CoV-2 viruses done at home without a prescription. . . . → Read More: FDA Authorizes Non-Prescription Covid-19 Test

NIH Assessing Home Covid-19 Diagnostic with App

QuickVue test package

A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-19 diagnostics for widespread use. . . . → Read More: NIH Assessing Home Covid-19 Diagnostic with App

ALS Trial Results Deemed Insufficient for FDA Approval

Neurons illustration

An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use. . . . → Read More: ALS Trial Results Deemed Insufficient for FDA Approval